Morgan Stanley Dyadic International Inc Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Dyadic International Inc stock. As of the latest transaction made, Morgan Stanley holds 5,654 shares of DYAI stock, worth $5,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,654

Previous 5,654 -0.0%

Holding current value

$5,710

Previous $9,000 22.22%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.0 - $1.97 $6,600 - $13,002	-6,600 Reduced 53.86%	5,654 $9,000
Q3 2024 May 14, 2025	BUY	$1.04 - $1.55 $12,272 - $18,290	11,800 Added 2599.12%	12,254 $12,000
Q3 2024 Nov 14, 2024	BUY	$1.04 - $1.55 $12,272 - $18,290	11,800 Added 2599.12%	12,254 $12,000
Q2 2024 May 14, 2025	SELL	$1.39 - $2.27 $7,227 - $11,804	-5,200 Reduced 91.97%	454 $0
Q3 2023 Nov 15, 2023	SELL	$1.71 - $2.08 $8,550 - $10,400	-5,000 Reduced 91.68%	454 $0
Q1 2023 May 15, 2023	SELL	$1.25 - $1.86 $27 - $40	-22 Reduced 0.4%	5,454 $9,000
Q4 2022 Feb 14, 2023	SELL	$1.18 - $2.32 $1,209 - $2,378	-1,025 Reduced 15.77%	5,476 $6,000
Q3 2022 Nov 14, 2022	BUY	$1.65 - $3.42 $77 - $160	47 Added 0.73%	6,501 $12,000
Q2 2022 Oct 27, 2022	SELL	$1.85 - $3.22 $11,179 - $19,458	-6,043 Reduced 48.36%	6,454 $20,000
Q2 2022 Aug 15, 2022	SELL	$1.85 - $3.22 $11,179 - $19,458	-6,043 Reduced 48.36%	6,454 $20,000
Q1 2022 Oct 27, 2022	BUY	$3.01 - $4.81 $18,189 - $29,066	6,043 Added 93.63%	12,497 $38,000
Q1 2022 May 13, 2022	BUY	$3.01 - $4.81 $15,949 - $25,488	5,299 Added 73.62%	12,497 $38,000
Q4 2021 Feb 14, 2022	SELL	$3.36 - $5.34 $117 - $186	-35 Reduced 0.48%	7,198 $33,000
Q3 2021 Nov 15, 2021	BUY	$3.3 - $6.49 $23,868 - $46,942	7,233 New	7,233 $41,000

Others Institutions Holding DYAI

# of Institutions

Shares Held

5.06M

Call Options Held

13K

Put Options Held

500

View Full List

About DYADIC INTERNATIONAL INC

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $28.7M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

More about DYAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account